相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)
Roger S. Kirby et al.
BJU INTERNATIONAL (2009)
SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer
David S. Rickman et al.
CANCER RESEARCH (2009)
Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection
Martin Schostak et al.
JOURNAL OF UROLOGY (2009)
A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
Rolf I. Skotheim et al.
MOLECULAR CANCER (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression
Raymond A. Clarke et al.
PLOS ONE (2009)
New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer
Shahrokh F. Shariat et al.
BJU INTERNATIONAL (2008)
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
G. Attard et al.
BRITISH JOURNAL OF CANCER (2008)
The role of SPINK1 in ETS rearrangement-negative prostate cancers
Scott A. Tomlins et al.
CANCER CELL (2008)
Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
Karin G. Hermans et al.
CANCER RESEARCH (2008)
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations:: Identification of DDX5-ETV4 fusion protein in prostate cancer
Bo Han et al.
CANCER RESEARCH (2008)
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
Bharathi Laxman et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2 : ETV5 and SLC45A3 : ETV5 gene fusions in prostate cancer
Beth E. Helgeson et al.
CANCER RESEARCH (2008)
A multicenter evaluation of the PCA3 molecular urine test: Pre-analytical effects, analytical performance, and diagnostic accuracy
Lori J. Sokoll et al.
CLINICA CHIMICA ACTA (2008)
Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species
Roopali Roy et al.
CLINICAL CANCER RESEARCH (2008)
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Alexander Haese et al.
EUROPEAN UROLOGY (2008)
Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer
Jens Koellerrmann et al.
EUROPEAN UROLOGY (2008)
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
Sunita R. Setlur et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
PCA3 molecular urine assay correlates with prostate cancer tumor volume: Implication in selecting candidates for active surveillance
Hiroyuki Nakanishi et al.
JOURNAL OF UROLOGY (2008)
PCA3: A molecular urine assay for predicting prostate biopsy outcome
Ina L. Deras et al.
JOURNAL OF UROLOGY (2008)
A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants
Qing Lu et al.
NUCLEIC ACIDS RESEARCH (2008)
Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer
Sooryanarayana Varambally et al.
NEOPLASIA (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers
Ashish B. Rajput et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
TMPRSS2-ERG fusion heterogeneity in Multifocal prostate cancer: Clinical and biologic implications
Marc Barry et al.
UROLOGY (2007)
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer
Daphne Hessels et al.
CLINICAL CANCER RESEARCH (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
Morphological features of TMPRSS2-ERG gene fusion prostate cancer
J-M Mosquera et al.
JOURNAL OF PATHOLOGY (2007)
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
Rohit Mehra et al.
MODERN PATHOLOGY (2007)
Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells
Xuesong Gu et al.
CANCER RESEARCH (2007)
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis
Jacques Lapointe et al.
MODERN PATHOLOGY (2007)
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
Leonard S. Marks et al.
UROLOGY (2007)
Urinary markers for prostate cancer
Michelle R. Downes et al.
BJU INTERNATIONAL (2007)
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Sangkil Nam et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Molecular PCA3 diagnostics on prostatic fluid
Martijn P. M. Q. van Gis et al.
PROSTATE (2007)
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2006)
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
Quantitative multi-gene expression profiling of primary prostate cancer
Uta Schmidt et al.
PROSTATE (2006)
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
Bharathi Laxman et al.
NEOPLASIA (2006)
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions
Nuno Cerveira et al.
NEOPLASIA (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
Maria Johansson Soller et al.
GENES CHROMOSOMES & CANCER (2006)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Urine markers as possible tools for prostate cancer screening:: Review of performance characteristics and practicality
H Müller et al.
CLINICAL CHEMISTRY (2006)
Prostate-specific antigen: Update 2006
SJ Freedland et al.
UROLOGY (2006)
NRG1 gene rearrangements in clinical breast cancer:: identification of an adjacent novel amplicon associated with poor prognosis
LM Prentice et al.
ONCOGENE (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
IM Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Use of thymosin β15 as a urinary biomarker in human prostate cancer
LM Hutchinson et al.
PROSTATE (2005)
Annexins:: Linking Ca2+ signalling to membrane dynamics
V Gerke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
G Petrovics et al.
ONCOGENE (2005)
Use of multiple biomarkers for a molecular diagnosis of prostate cancer
KA Landers et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity
GI Botchkina et al.
CLINICAL CANCER RESEARCH (2005)
Urinary/serum prostate-specific antigen ratio:: Comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection
J Irani et al.
UROLOGY (2005)
Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas
G Alipov et al.
HISTOPATHOLOGY (2005)
Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia
C Vicentini et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy:: A longitudinal study of protein kinetics throughout tumor progression and therapy
LW Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results
LE Crocitto et al.
UROLOGY (2004)
Identification and proteomic profiling of exosomes in human urine
T Pisitkun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A novel diagnostic test for prostate cancer emerges from the determination of α-methylacyl-coenzyme A racemase in prostatic secretions
PJ Zielie et al.
JOURNAL OF UROLOGY (2004)
The expression and significance of survivin mRNA in urinary bladder carcinomas
HD Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
DD3PCA3 RNA analysis in urine -: A new perspective for detecting prostate cancer
M Tinzl et al.
EUROPEAN UROLOGY (2004)
uPM3, a new molecular urine test for the detection of prostate cancer
YF Fradet et al.
UROLOGY (2004)
Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: A pilot study
I Rehman et al.
UROLOGY (2004)
Trefoil factor 3 is overexpressed in human prostate cancer
IP Garraway et al.
PROSTATE (2004)
Prostate cancer detection on urinalysis for α methylacyl coenzyme A racemase protein
CG Rogers et al.
JOURNAL OF UROLOGY (2004)
Urinary 8-hydroxydeoxyguano sine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers
CC Chiou et al.
CLINICA CHIMICA ACTA (2003)
DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
D Hessels et al.
EUROPEAN UROLOGY (2003)
Molecular biology of the Ets family of transcription factors
T Oikawa et al.
GENE (2003)
Repeat prostate biopsy: Who, how and when? A review
B Djavan et al.
EUROPEAN UROLOGY (2002)
α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients:: Detection of mutated TMPRSS2 form in a case of aggressive disease
MH Vaarala et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
DNA-based detection of prostate cancer in urine after prostatic massage
C Goessl et al.
UROLOGY (2001)
The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage
FH Meid et al.
JOURNAL OF UROLOGY (2001)
Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers
D Gavrilov et al.
EUROPEAN JOURNAL OF CANCER (2001)
Urine detection of survivin and diagnosis of bladder cancer
SD Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Urinary tissue factor levels in patients with bladder and prostate cancer
BA Lwaleed et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)
Prostate cancer detection at low prostate specific antigen
FH Schroder et al.
JOURNAL OF UROLOGY (2000)
分享论文
